Clinical Trials List
2024-10-01 - 2032-12-31
Phase I/II
Recruiting3
ICD-10C16.9
Malignant neoplasm of stomach, unspecified
ICD-10C7A.092
Malignant carcinoid tumor of the stomach
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9151.9
Malignant neoplasm of stomach, unspecified
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Ta-Ching Chen 無
- Kun-Huei Yeh 無
- 莊建淮 無
- 呂理駿 無
- YU-YUN SHAO 無
- 郭弘揚 無
- 陳國興 無
- 梁逸歆 無
- TSUNG-HAO LIU 無
- Ying-Chun Shen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yi-Ping Hung 無
- Hao-Wei Teng 無
- 邱乃祈 無
- San-Chi Chen 無
- 姜乃榕 無
- 唐振育 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chiu Hung Chiu 無
- 顏志傑 無
- Yu-Min Yeh 無
- 劉奕廷 無
- 邱彥程 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
9 participants
-
Global
180 participants
